# Apremilast for Alcohol Use Disorder Treatment in Women and Men

> **NCT06324435** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Yale University** · enrollment: 10 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT06324435
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-08
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06324435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06324435, "Apremilast for Alcohol Use Disorder Treatment in Women and Men". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06324435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*